Issue 24, 2022

Carrier-free nanomedicine for enhanced photodynamic tumor therapy through glutathione S-transferase inhibition

Abstract

Antioxidant-defense systems of tumor cells protect them from oxidative damage. Herein, a carrier-free nanomedicine is developed based on chlorine e6 (Ce6) and coniferyl ferulate (Con), which inhibits glutathione S-transferase (GST) activity to hamper antioxidant systems and amplify intracellular oxidative stress for enhanced photodynamic therapy.

Graphical abstract: Carrier-free nanomedicine for enhanced photodynamic tumor therapy through glutathione S-transferase inhibition

Supplementary files

Article information

Article type
Communication
Submitted
13 Jan 2022
Accepted
23 Feb 2022
First published
24 Feb 2022

Chem. Commun., 2022,58, 3917-3920

Carrier-free nanomedicine for enhanced photodynamic tumor therapy through glutathione S-transferase inhibition

X. Li, R. Kong, Y. Li, J. Huang, X. Zhou, S. Li and H. Cheng, Chem. Commun., 2022, 58, 3917 DOI: 10.1039/D2CC00235C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements